US · Healthcare

Oncolytics Biotech Inc (ONCY)

Biotechnology

Oncolytics Biotech Inc (ONCY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ONCY

P/E ratio

25.00

Oncolytics Biotech Inc (ONCY) — FAQ

What is ONCY's P/E ratio?

The price-to-earnings (P/E) ratio for Oncolytics Biotech Inc (ONCY) is 25.00 (data as of 2026-05-23).

Does Oncolytics Biotech Inc pay a dividend?

Dividend yield is not available in the current snapshot for Oncolytics Biotech Inc (ONCY). Check the MyAverix Finance app for the latest dividend data.

What sector is Oncolytics Biotech Inc in?

Oncolytics Biotech Inc (ONCY) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ONCY listed on?

ONCY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)